Both in Pharmaceuticals
Azitra vs Apimeds Pharmaceuticals US
Over the past year AZTR returned −82.7% and APUS returned −89.3%; their daily moves had a correlation of -0.01.
AZTR −82.7% APUS −89.3%Growth of $1, one year, split-adjusted
| Metric | AZTR | APUS |
|---|---|---|
| Price | $0.8157 | $2.92 |
| Market cap | $4.9M | $4.4M |
| Today | −7.71% | −1.68% |
| 1 month | −37.3% | −59.0% |
| 6 months | −66.7% | −85.0% |
| Year to date | −69.2% | −82.2% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $6.7M | -$8.6M |
| Dividend yield | — | — |
| Volatility (60d) | 222.1% | 263.3% |
| Short % of float | 0.2% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).